SCHEMBL8204082

SCHEMBL8204082

CC(C)(C)Oc1ccc(CC2SC(=O)NC2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.60
FFAR1 O14842 4/20 0.59
PPARA Q07869 2/20 0.59
CYP3A4 P08684 2/20 0.57
ALDH1A1 P00352 2/20 0.57
MEN1 O00255 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 1/20 0.57
KMT2A Q03164 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
PPARG P37231 11/20 0.56
HRH3 Q9Y5N1 1/20 0.53
RXRA P19793 1/20 0.53
MAOA P21397 1/20 0.52
CISD1 Q9NZ45 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19217748 0.86 MAPT (0.60) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL3840336 0.84 FFAR1 (0.65) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL9570562 0.83 FFAR1 (0.63) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL8312939 0.83 MAPT (0.69) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL9570559 0.83 MAPT (0.83) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL9570614 0.82 FFAR1 (0.62) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL19217579 0.81 PPARG (0.67) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL19828508 0.81 PPARG (0.67) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL6225175 0.81 FFAR1 (0.67) MAPTFFAR1PPARACYP3A4ALDH1A1
SCHEMBL2608677 0.81 PPARG (0.67) MAPTFFAR1PPARACYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018746-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed